Indian drugmakers set to capitalize on Cymbalta generics


Approval for the generic version of Eli Lilly’s Cymbalta duloxetine by the US health regulator (The…

Asia-PacificAurobindo PharmaCymbaltaDr Reddy's LaboratoriesDuloxetine HclEli LillyGenericsHealthcareIndiaLupinMarkets & MarketingNeurologicalPatentsSun Pharmaceutical IndustriesTorrent Pharmaceuticals

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent


Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

US Supreme Court ruling in Novo Nordisk Prandin case favors generic drugmakers


The US Supreme Court yesterday reversed the US Court of Appeals for the Federal Circuit's April 2010…

Caraco PharmaceuticalDiabetesGenericsLegalNorth AmericaNovo NordiskPatentsPharmaceuticalPrandiMetPrandinrepaglinideSun Pharmaceutical Industries

Sanofi prevails over Sun Pharma in Eloxatin patent suit; another generic Lovenox approved


There was good and bad news for French drug major Sanofi (Euronext: SAN) yesterday, when the US District…

AmphastarCardio-vascularEloxatinGenericsLovenoxOncologyPatentsPharmaceuticalSanofiSun Pharmaceutical IndustriesWatson Pharmaceuticals

District Court rules in favor of Nycomed/Pfizer’s US patent for Protonix


Judge Jose Linares of the US District Court for the District of New Jersey has confirmed the jury verdict…

Gastro-intestinalsGenericsLegalNorth AmericaNycomedPatentsPfizerPharmaceuticalProtonixSchwarz PharmaSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Back to top